Jasper Therapeutics Inc. (NASDAQ: JSPR)
$21.9350
+0.0950 ( -0.07% ) 44.0K
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Market Data
Open
$21.9350
Previous close
$21.8400
Volume
44.0K
Market cap
$328.61M
Day range
$21.1660 - $23.0000
52 week range
$4.0000 - $31.0100
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 73 | Nov 07, 2024 |
8-k | 8K-related | 16 | Nov 07, 2024 |
8-k | 8K-related | 16 | Oct 15, 2024 |
4 | Insider transactions | 1 | Sep 12, 2024 |
10-q | Quarterly Reports | 75 | Aug 13, 2024 |
3 | Insider transactions | 2 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
8-k | 8K-related | 16 | Jun 20, 2024 |
4 | Insider transactions | 2 | Jun 12, 2024 |
8-k | 8K-related | 18 | Jun 12, 2024 |